1)Ohguro N, Sonoda K, Takeuchi M et al:The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 56:432-435, 2012
2)Wieringa WG, Wieringa JE, ten Dam-van Loon NH et al:Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology 120:379-386, 2013
3)Keino H, Watanabe T, Taki W et al:Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol 94:1459-1463, 2010
4)Miyanaga M, Takase H, Ohno-Matsui K:Anti-neutrophil cytoplasmic antibody-associated ocular manifestations in Japan:a review of 18 patients. Ocul Immunol Inflamm 29:991-996, 2021
5)Hoffman GS, Kerr GS, Leavitt RY et al:Wegener granulomatosis:an analysis of 158 patients. Ann Intern Med 116:488-498, 1992
6)厚生労働省難治性疾患政策研究事業難治性血管炎に関する調査研究班・他:血管炎症候群の診療ガイドライン(2017年改訂版).54-59,2017〔https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/.JSC2017_isobe_h.pdf(閲覧日:2024年1月15日)〕
7)Ungprasert P, Crowson CS, Cartin-Ceba R et al:Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis:a retrospective cohort study. Rheumatology(Oxford) 56:1763-1770, 2017
8)Sada KE, Yamamura M, Harigai M et al:Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16:R101, 2014
9)Majumder PD, Sudharshan S, George AE et al:Antineutrophil cytoplasmic antibody-positive scleritis:clinical profile of patients from a tuberculosis-endemic region. Indian J Ophthalmol 66:1587-1591, 2018
10)Perray L, Nguyen Y, Clavel Refregiers G et al:ANCA-associated scleritis:impact of ANCA on presentation, response to therapy and outcome. Rheumatology(Oxford) 63:329-337, 2024
11)松浦沙綾・相馬亮子・石田友香・他:超広角光干渉断層計での経過観察が有用であった後部強膜炎の1例.あたらしい眼科37:891-895,2020